Have your own idea? Try our Stock Screener
Polish (WIG) Clinical Research and Equipment Industry Analysis
UpdatedApr 20, 2026
DataAggregated Company Financials
Companies4
- 7D6.1%
- 3M-11.7%
- 1Y0.0007%
- YTDn/a
In the last week, the Clinical Research and Equipment industry is up 6.9%, with Selvita up 8.6%. The industry has been flat over the past 12 months despite the gain this week. Looking forward, earnings are forecast to grow by 32% annually.
Industry Valuation and Performance
Has the Polish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 20 Apr 2026 | zł1.3b | zł459.0m | -zł102,646,524.00 | 801.5x | -12.4x | 2.8x |
| Wed, 18 Mar 2026 | zł1.3b | zł464.6m | -zł124,641,157.00 | n/a | -10.1x | 2.7x |
| Fri, 13 Feb 2026 | zł1.4b | zł464.6m | -zł124,641,157.00 | n/a | -11.5x | 3.1x |
| Sun, 11 Jan 2026 | zł1.5b | zł464.6m | -zł124,641,157.00 | n/a | -12.2x | 3.3x |
| Tue, 09 Dec 2025 | zł1.6b | zł464.6m | -zł124,641,157.00 | n/a | -12.6x | 3.4x |
| Thu, 06 Nov 2025 | zł1.4b | zł507.6m | -zł114,663,001.00 | 1598.7x | -12.1x | 2.7x |
| Sat, 04 Oct 2025 | zł1.4b | zł507.7m | -zł114,663,001.00 | 1460.5x | -12.3x | 2.8x |
| Mon, 01 Sep 2025 | zł1.4b | zł460.9m | -zł129,094,851.00 | 37.8x | -11.1x | 3.1x |
| Wed, 30 Jul 2025 | zł1.6b | zł461.1m | -zł128,888,382.00 | 39.1x | -12.1x | 3.4x |
| Fri, 27 Jun 2025 | zł1.4b | zł457.8m | -zł130,948,382.00 | n/a | -10.4x | 3x |
| Sun, 25 May 2025 | zł1.4b | zł457.8m | -zł130,428,382.00 | n/a | -10.5x | 3x |
| Tue, 22 Apr 2025 | zł1.4b | zł452.3m | -zł123,092,243.00 | 49.3x | -11.7x | 3.2x |
| Thu, 20 Mar 2025 | zł1.5b | zł440.9m | -zł62,900,243.00 | 32.1x | -23.4x | 3.3x |
| Sat, 15 Feb 2025 | zł1.7b | zł427.0m | -zł64,267,017.00 | 15.6x | -26.3x | 4x |
| Mon, 13 Jan 2025 | zł2.0b | zł427.0m | -zł65,964,174.00 | 16.3x | -29.7x | 4.6x |
| Wed, 11 Dec 2024 | zł2.3b | zł427.0m | -zł65,964,174.00 | 18.1x | -35.2x | 5.4x |
| Fri, 08 Nov 2024 | zł2.2b | zł413.2m | -zł64,500,689.00 | 21.3x | -34x | 5.3x |
| Sun, 06 Oct 2024 | zł2.4b | zł413.2m | -zł64,500,689.00 | 22x | -37.1x | 5.8x |
| Tue, 03 Sep 2024 | zł2.5b | zł413.4m | -zł37,576,869.00 | 18.2x | -65.7x | 6x |
| Thu, 01 Aug 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 19x | -77x | 6x |
| Sat, 29 Jun 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 19.2x | -76.5x | 5.9x |
| Mon, 27 May 2024 | zł2.7b | zł413.5m | -zł32,092,283.00 | 20.1x | -82.6x | 6.4x |
| Wed, 24 Apr 2024 | zł2.5b | zł421.0m | -zł26,364,957.00 | 18.3x | -95.8x | 6x |
| Fri, 22 Mar 2024 | zł2.6b | zł478.9m | -zł71,866,957.00 | 47.1x | -35.5x | 5.3x |
| Sun, 18 Feb 2024 | zł2.6b | zł495.9m | -zł52,637,957.00 | 45x | -48.6x | 5.2x |
| Tue, 16 Jan 2024 | zł2.5b | zł495.2m | -zł50,454,191.00 | 46.4x | -49.4x | 5x |
| Thu, 14 Dec 2023 | zł2.6b | zł495.2m | -zł50,454,191.00 | 45x | -52.3x | 5.3x |
| Sat, 11 Nov 2023 | zł2.5b | zł511.9m | -zł35,664,342.00 | 31x | -69.1x | 4.8x |
| Mon, 09 Oct 2023 | zł2.8b | zł515.2m | -zł43,528,934.00 | 39.9x | -64x | 5.4x |
| Wed, 06 Sep 2023 | zł2.8b | zł507.8m | -zł51,598,105.00 | 42.5x | -53.7x | 5.5x |
| Fri, 04 Aug 2023 | zł2.9b | zł512.4m | -zł61,559,268.00 | 46.7x | -46.6x | 5.6x |
| Sun, 02 Jul 2023 | zł2.8b | zł512.4m | -zł61,559,268.00 | 43.1x | -44.9x | 5.4x |
| Tue, 30 May 2023 | zł2.9b | zł504.7m | -zł60,194,797.00 | 46.5x | -47.8x | 5.7x |
| Thu, 27 Apr 2023 | zł2.8b | zł505.4m | -zł64,921,034.00 | 66.8x | -42.6x | 5.5x |
Price to Earnings Ratio
-42.6x
Current Industry PE
- Investors are pessimistic on the Polish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.5x is higher than the industry's current PS ratio of 2.8x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 3.2% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does Polish Clinical Research and Equipment compare with similar industries?
| PL Market | 2.13% | |
| Healthcare | 3.87% | |
| Life Sciences | 6.13% | |
| Clinical Research and Equipment | 6.13% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SLV Selvita | zł36.25 | 11.5% +zł68.8m | 19.2% | PE818.4x | |
| RVU Ryvu Therapeutics | zł25.05 | 2.2% +zł12.7m | -11.8% | PS6.6x | |
| NNG NanoGroup | zł2.54 | 1.6% +zł1.7m | -28.2% | PB10x |